Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Histrelin. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GNRHR known ✓ | P30968 | 2/20 | 0.77 |
| ▸ | ABCC2 | Q92887 | 1/20 | 0.76 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.71 |
| ▸ | APLNR | P35414 | 5/20 | 0.60 |
| ▸ | CXCR4 | P61073 | 2/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Histrelin SCHEMBL17881 | 1.00 | GNRHR (0.77) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Histrelin SCHEMBL29405757 | 1.00 | GNRHR (0.77) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Histrelin SCHEMBL84261 | 1.00 | GNRHR (0.76) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Histrelin SCHEMBL29372688 | 0.99 | ABCC2 (0.78) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Histrelin SCHEMBL5327685 | 0.99 | ABCC2 (0.78) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Histrelin SCHEMBL18715 | 0.99 | ABCC2 (0.78) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Histrelin SCHEMBL22288995 | 0.94 | GNRHR (0.67) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Histrelin SCHEMBL1650282 | 0.94 | GNRHR (0.67) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL4585 | 0.94 | GNRHR (0.86) | GNRHRABCC2PTGS1APLNRCXCR4 | |
| Leuprolide SCHEMBL7751433 | 0.94 | GNRHR (0.86) | GNRHRABCC2PTGS1APLNRCXCR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6204054-B1 | MIXTURE OF ALBUMIN, ANTIBODY, PEPTIDES AND PROTEIN DISULPHIDE ISOMERASE; DRY POWDERS; INHALATION | ANDARIS LIMITED (GB) | 2001-03-20 | — | — | US | claimed |
| EP-0921808-B1 | NON-AQUEOUS POLAR APROTIC PEPTIDE FORMULATIONS | ALZA CORP (US) | 2002-09-18 | — | — | EP | disclosed |